Signet Financial Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-329
Closed -$32K 827
2021
Q4
$32K Buy
+329
New +$32K ﹤0.01% 673